When Stock Prices Fall, Antidepressant Prescriptions Rise
A new study finds that is particularly true for people nearing retirement.
A new study finds that is particularly true for people nearing retirement.
Feeling depressed when the stock market is down? You have plenty of company. According to a recent study, when stock prices fall, the number of antidepressant prescriptions rises.
The researchers examined the connection by first creating local stock indexes, combining companies with headquarters in the same state. Academic research has shown that investors tend to own more local stocks in their portfolios, either because of employee-stock-ownership plans or because they have more familiarity with those companies.
The researchers then looked at about 300 metropolitan statistical areas, which are regions encompassing a city with 50,000 people and the surrounding towns, tracking changes in local stock prices and the number of antidepressant prescriptions in each area over a two-year period. They found that when local stock prices dropped about 12.8% over a two-week period, antidepressant prescriptions increased 0.42% on average. A similar relationship was seen in smaller stock-price drops as well. When local stock prices fell by about 6.4%, antidepressant prescriptions increased about 0.21%.
“Our findings suggest that as the stock market declines, more people experience stress and anxiety, leading to an increase in prescriptions for antidepressants,” says Chang Liu , an assistant professor at Ball State University’s Miller College of Business in Muncie, Ind., and one of the paper’s co-authors. The analysis controlled for other factors that could influence antidepressant usage, like unemployment rates or the season.
In a comparison of age groups, those aged 46 to 55 were the most likely to get antidepressant prescriptions when local stocks dropped.
“People in this age group may be more sensitive to changes in their portfolio compared with a younger cohort, who are further from retirement, and older cohorts who may own less stocks and more bonds since they are nearing retirement,” says Maoyong Fan , a professor at Ball State University and co-author of the study.
When the authors looked at demand for psychotherapy during periods of declining stock prices their findings were similar. When local stock prices dropped by about 12.8% over a two-week period, the number of psychotherapy visits billed to insurance providers increased by about 0.32%. They also found a correlation between local stock returns and certain illnesses associated with depression, such as insomnia, peptic ulcer, abdominal pain, substance abuse and myocardial infarction. But when the authors looked at other insurance claims, like antibiotics prescriptions, they found no relationship with changes in local stock prices.
By contrast, for periods when stocks rise, the authors didn’t see a drop in psychological interventions. They found no statistical relationship between rising local stock prices and the number of antidepressant prescriptions, for example, which the authors believe makes sense.
“Once a patient is prescribed an antidepressant, it’s unlikely that a psychiatrist would stop antidepressant prescriptions immediately,” says Liu.
One practical implication of the study, Liu adds, is that investors should be aware of their emotional state when the market dips before they make investment decisions.
A rare slice of Sydney history, Coolabah blends Victorian grandeur with modern luxury in the heart of Greenwich; once home to Lane Cove’s first Lord Mayor and now listed with a $6.5m guide.
Bhutan is pioneering a new frontier in travel by allowing tourists to pay for flights, visas, hotels and even fruit stalls using cryptocurrency via Binance Pay.
Citizen Kanebridge member Marcel Zalloua delivered a standout result in Tigani Motorsport’s Mercedes-AMG GT3 Evo, backed by Robb Report Australia & New Zealand and Citizen Kanebridge.
Sydney’s night sky lit up with speed and precision when Tigani Motorsport’s Mercedes-AMG GT3 Evo charged to a second-place finish in the Pro-Am class during Race 1 of the GT World Challenge Australia at Sydney Motorsport Park.
Behind the wheel was entrepreneur and Citizen Kanebridge member Marcel Zalloua, partnered with Supercars regular Thomas Randle in a formidable one-off pairing that impressed from the outset.
The result marks a major milestone for Zalloua, a returning driver with previous success in the Am class, and continues Tigani Motorsport’s strong form in the 2025 season.
Zalloua is part of Citizen Kanebridge, an invitation-only club based in Sydney.
The club curates exclusive events, thought-leadership forums and networking opportunities for high-achieving individuals across investment, innovation and entrepreneurship.
The sleek #44 AMG GT3 Evo also sported a high-end lineup of sponsors, including Robb Report Australia & New Zealand and Citizen Kanebridge, alongside other premium backers — all part of a strategy to align the vehicle with luxury, performance and lifestyle excellence.
Race 1 saw the Zalloua-Randle duo execute a clean, strategic drive to claim the podium, with the car showing strong pace under lights.
Although Race 2 proved more challenging with a ninth-place finish in class, their combined effort across the weekend delivered valuable points to Tigani Motorsport’s championship campaign.
Tigani Motorsport continues to cement itself as a serious contender in the GT racing scene, with smart driver pairings, high-calibre partnerships, and a commitment to performance both on and off the track.
The U.S. now has more billionaires than China for the first time in a decade, driven by AI and a booming stock market.
Market downdrafts tempt people to adjust their investments, but that’s not always a wise choice.